• IMMUNE NETWORK
• /
• 제13권1호
• /
• pp.25-29
• /
• 2013

Ribavirin is an antiviral drug used in combination with pegylated interferon-${\alpha}$ (IFN-${\alpha}$) for the treatment of hepatitis C virus (HCV) infection. Recently, ribavirin was reported to inhibit the suppressive activity of regulatory T (Treg) cells. In the present study, we re-evaluated the effect of ribavirin on $CD4^+$ $CD4^+$ $CD25^+$ Treg cells from normal donors. First, we examined the expression of CTLA-4 and CD39, which are known to play a role in the suppressive function of Treg cells. We found that ribavirin treatment did not modulate the expression of CTLA-4 and CD39 in Treg cells. We also studied the effect of ribavirin on Treg cells in the presence of IFN-${\alpha}$; however, the expression of CTLA-4 and CD39 in Treg cells was not changed by ribavirin in the presence of IFN-${\alpha}$. Next, we directly evaluated the effect of ribavirin on the suppressive activity of Treg cells in the standard Treg suppression assay, by co-culturing CFSE-labeled non-Treg $CD4^+$ T cells with purified Treg cells. We found that ribavirin did not attenuate the suppressive activity of Treg cells. Taken together, while ribavirin reversed Treg cell-mediated suppression of effector T cells in the previous study, we herein demonstrate that ribavirin does not impair the suppressive activity of Treg cells.

• Journal of Yeungnam Medical Science
• /
• 제3권1호
• /
• pp.209-213
• /
• 1986

소아만성B형간염 환아 24명에게 항virus제인 ribavirin을 15mg/kg/day로 14일간 경구투여한 군과 투여하지 않은 대조군으로 나누어 12개월간 혈청 HBsAg과 HBeAg을 추적 검사한 결과 두군 모두에서 HBsAg과 HBeAg의 감소를 볼 수 없었으므로 ribavirin의 소아만성B형간염에 대한 치료효과는 없는것으로 보여진다. 또한 ribavirin 치료에 따른 특별한 부작용도 볼 수 없었다.

• Clinical and Experimental Pediatrics
• /
• 제63권2호
• /
• pp.52-55
• /
• 2020

Background: Immunomodulatory properties of interferon (IFN) have been documented. It may induce autoimmune diseases such as autoimmune thyroiditis with hypo- or hyperthyroidism. In addition, it may impair thyroid hormone synthesis through affecting iodide organification in thyroid gland. Purpose: The aim of this study was to describe thyroid function tests disturbances in children with chronic hepatitis C (CHC) receiving pegylated interferon-alpha (PEG IFN-α) plus ribavirin. Methods: Fifty children with CHC virus infection who received combined pegylated interferon-alpha with ribavirin were selected. Other 50 apparently healthy children of matched age and sex (considered as control group) were selected. All children (100) were subject to liver function tests, virological studies, and follow-up of thyroid function test during and after the treatment course. Results: Our study showed that 28% of children received combined PEG IFN-α plus ribavirin showed subclinical hypothyroidism. After 24 weeks treatment with combined therapy of IFN plus ribavirin, the mean level of thyroid stimulating hormone (TSH) was 3.23±88 mU/mL, while TSH was 1.16±0.77 mU/mL before starting treatment. On the other hand, mean TSH was 1.09±0.92 mU/mL in normal control group. Conclusion: This study revealed an association between subclinical thyroid dysfunction and treatment with IFN-alpha and ribavirin in children. Further studies on larger number of patients and longer follow-up duration are recommended for further confirmation.

• 약학회지
• /
• 제33권6호
• /
• pp.361-364
• /
• 1989

The Synthesis of acyclic derivatives of ribavirin (2'-azido and halo seco derivatives) for the development of new antiviral agents is described. These acyclic nucleosides are synthesized from ribavirin by the method of ring opening reaction of sugar moietry.

• 약학회지
• /
• 제59권6호
• /
• pp.245-250
• /
• 2015

Middle East respiratory syndrome - coronavirus infection has posed substantial threat to public health with extremely high mortality rate in 2015. Although there are no approved novel medications for coronavirus, several antiviral agents such as ribavirin and interferon have been tried to MERS patients according to the in-vitro inhibitory effect, therapeutic effect on the animal model and experience from the severe acute respiratory syndrome - coronavirus infection. The aim of this study is to evaluate the clinical evidence of the antiviral treatment for MERS-CoV infection. After systematically searching the medical literature databases, I found five studies described the clinical efficacy of antiviral treatment on MERS patients. All of them were about the combination therapy of ribavirin and interferon (IFN). Two of them were retrospective cohort studies with quality of evidence (QOE) II and the others were observational study and case reports with QOE III. As a result of critical appraisal, it is concluded that none of those studies represented confirmatory clinical evidence of the efficacy of ribavirin and interferon combination therapy on MERS patients. Although Omrani et al. represented that ribavirin and IFN treatment had significantly improved survival at 14 days, it was not enough time to conclude the effect.

• BMB Reports
• /
• 제39권1호
• /
• pp.9-15
• /
• 2006

To prove whether error catastrophe /lethal mutagenesis is the primary antiviral mechanism of action of ribavirin against foot-and-mouth disease virus (FMDV). Ribavirin passage experiments were performed and supernatants of $Rp_1$ to $Rp_5$ were harvested. Morphological alterations as well as the levels of viral RNAs, proteins, and infectious particles in the BHK-21 cells infected using the supernatants of $Rp_1$ to $Rp_5$ and control were measured by microscope, real-time RT-PCR, western-blotting and plaque assays, respectively. The mutation frequency was measured by sequencing the complete P1- and 3D-encoding region of FMDV after a single round of virus infection from ribavirin-treated or untreated FMDV-infected cells. Ribavirin treatment for FMDV caused dramatically inhibition of multiplication in cell cultures. The levels of viral RNAs, proteins, and infectious particles in the BHK-21 cells infected were more greatly reduced along with the passage from $Rp_1$ to $Rp_5$, moreover, nucleocapsid protein could not be detected and no recovery of infectious virus in the supernatant or detection of intracellular viral RNA was observed at the $Rp_5$-infected cells. A high mutation rate, giving rise to an 8-and 11-fold increase in mutagenesis and resulting in some amino acid substitutions, was found in viral RNA synthesized at a single round of virus infection in the presence of ribavirin of $1000\;{\mu}M$ and caused a 99.7% loss in viral infectivity in contrast with parallel untreated control virus. These results suggest that the antiviral molecular mechanism of ribavirin is based on the lethal mutagenesis/error catastrophe, that is, the ribavirin is not merely an antiviral reagent but also an effective mutagen.

• Journal of Plant Biotechnology
• /
• 제43권3호
• /
• pp.391-396
• /
• 2016

본 연구는 Apple stem grooving virus (ASGV)에 감염된 배 (Pyrus pyrifolia L.) '만수'의 기내배양 식물체를 이용하여 효과적인 배 바이러스 무병화 기술을 알아보고자 수행하였다. 식물체의 경정조직을 잘라 열처리($37^{\circ}C$), 한냉처리($4^{\circ}C$), 항바이러스제인 ribavirin을 단독 또는 복합처리하였다. 처리기간은 2, 4, 8주였으며 ribavirin 농도는 20과 $40mg{\cdot}L^{-1}$이었다. 바이러스 제거율은 Reverse transcription polymerase chain reaction 분석으로 확인하였다. 신초 생존율은 2주간 한냉처리, 항바이러스제 단독처리와 한냉처리와 항바이러스제가 복합처리된 그룹에서 100%로 높았고 열처리에서 33.3%로 가장 낮았다. 단독으로 ribavirin을 처리한 그룹은 처리기간이 길수록 신초 생존율이 감소하는 경향이었다. ASGV 제거율은 2주간 ribavirin $40mg{\cdot}L^{-1}$ 농도로 처리한 그룹과 열처리와 ribavirin을 복합처리한 그룹에서 100%로 높았다. 한냉처리한 그룹의 바이러스 제거율은 16.7%로 가장 낮았으나 한냉처리와 ribavirin을 복합처리한 그룹에서는 43.3%로 향상되었다. 모든 처리에서 처리기간이 길수록 바이러스 제거율은 증가하였다. 본 실험을 통해 배 ASGV 제거에는 경정배양과 더불어 항바이러스제인 ribavirin을 $20mg{\cdot}L^{-1}$ 농도로 4주간 처리하거나 $40mg{\cdot}L^{-1}$ 농도로 2주간 단독처리만으로도 효과적으로 무병화가 가능할 것으로 판단되었다.

• Journal of Plant Biotechnology
• /
• 제5권2호
• /
• pp.101-105
• /
• 2003

To eradicate several viruses such as PVX, PVY, and PLRV which often cause considerable damages to the growth and yields of potatoes, several stems including shoot tips were excised from the potato plants grown for 50 days and electric shock was treated. Shoot tips excised from electric-shocked stems were transferred into the medium supplemented with antiviral compound, ribavirin to examine the combinatorial effect. When treated only with 20 mg/L ribavirin, PVX concentration in the regenerated plant-lets was slowly decreased as repeating sub-culture and finally, it took 32 weeks to reach completely PVX-free stock. With an electric shock treatment (10 mA electric current), all the replicates became free from PVY. However, PLRV was not completely eradicated from 94P70-4 and 93P29-3 lines even by treating with 10 mA electric shock. In this case, both electric shock and antiviral compound treatments in axillary buds from the stem segment were successful in eradicating viral contamination.

• Pediatric Infection and Vaccine
• /
• 제19권3호
• /
• pp.162-167
• /
• 2012

RSV는 2세 미만의 소아에서 급성 하기도 감염으로 인한 입원의 주원인이다. 특히 미숙아, 선천성 심폐질환, 면역결핍이 동반된 경우 주요 위험군으로 알려져 있다. 고위험군의 소아에서 중증 RSV 감염의 경우 리바비린 흡입요법이 허가가 되어 있으나 고비용, 안전성 등의 문제로 국내 임상에서의 사용은 매우 제한적인 실정이다. 저자들은 8개월 여환이 급성 림프구성 백혈병으로 관해유도요법 항암치료 중 발생한 RSV 폐렴으로 기흉, 기종격동, 호흡부전이 동반된 중증 감염을 경험하였다. 정맥용 면역글로불린, 경구 리바비린 투여에 반응이 없어 리바비린 흡입 치료를 시행하였고, 이후 임상적 호전을 경험하였기에 보고하는 바이다.

• 식물조직배양학회지
• /
• 제26권1호
• /
• pp.65-69
• /
• 1999

LSV 제거 효과를 조사하기 위하여 LSV에 감염된 나리 Casa Blanca를 재료로 기내 배양 중에 화학약제 및 열처리를 단독 또는 병형처리하였다. 단독처리시 ribavirin 20 mg/L과 열처리 35$^{\circ}C$/$25^{\circ}C$ (주간/야간)에서 식물의 생육 및 LSV 제거율(각각 86%, 80%)이 ekfs 처리보다 좋았다. 이 두 처리를 병행하였을 경우, 열처리 기간이 길수록 LSV 제거율은 증가하는 경향이었으며, 열처리 16주의 모든 처리에서 ribavirin 농도와 관계없이 100%의 LSV 제거 효과를 보였다. 토양 정식 후 LSV 무병화 정도는 ribavirin 20 mg/L 농도와 열처리 8주 병행처리에서 12개체 중 8개체가 무병화를 보여 가장 효과적이었으며, 전체 조사 수를 기준으로 했을 때 약 21% 정도의 무병화가 유지되었고, 나머지는 토양의 자연 조건에서 다시 바이러스의 복제, 증식이 되는 것으로 보인다.